How is a prospectus put together, and how long does it stay valid?
Content and form, the standard format and 300-page limit, the summary, base prospectuses, universal registration documents and frequent issuers, validity, and supplements.
By the ExamPass CY editorial teamLast reviewed 7 min read
Topic 3 of 6 · all topics in this chapter
On this page
- Short answer
- Drawing up the prospectus at a glance
- In the exam
- What must a prospectus contain, and in what form?
- What goes in the summary and in a base prospectus?
- How do universal registration documents, validity and supplements work?
- How to think about it
- Common mistakes
- Further ESMA work on supplements and summaries
- Legal references
- Practise this topic
Short answer
A prospectus gives the information material to an informed assessment of the issuer, the securities' rights and the reasons for the issue. It is a single document or separate documents: a registration document (issuer), a securities note (securities) and a summary of at most 7 pages in four sections. A base prospectus with final terms may cover non-equity securities. A universal registration document may be filed without approval after one approved year. A prospectus is valid for 12 months after approval if kept up to date by supplements, each approved within 5 working days.
Drawing up the prospectus at a glance
| Point | Rule |
|---|---|
| Form | One document, or three: registration document (issuer), securities note (securities) and summary |
| Format (since 5 June 2026) | Standardised format and sequence; share prospectus at most 300 A4 sides |
| Summary | At most 7 A4 sides; four sections in fixed order; at most 15 risk factors; no cross-references |
| No summary needed | Non-equity admission to a qualified-investor-only market, or with a €100,000 denomination; either is enough |
| Base prospectus | Non-equity securities and warrants; 'form of the final terms' template and web address for final terms |
| Universal registration document | Issuers on a regulated market or MTF; filed without approval after one approved year (since 4 December 2024) |
| Frequent issuer | Prospectus in separate documents: decision within 5 working days, after 5 working days' notice |
| Validity | 12 months from approval; from the securities note if separate; URD from approval or filing |
| Supplement | Up to offer close or start of trading, if later; approved within 5 working days; 3 working days to withdraw |
Source: Regulation (EU) 2017/1129, Articles 6–10, 12, 20(6) and 23, as amended by Regulation (EU) 2024/2809; Delegated Regulation (EU) 2026/1061.
In the exam
The exam is written from the exam material, which predates the changes below. Expect its answer. If that answer is not among the options and the current rule is, choose the current rule.
Filing a URD without approval
Exam material: An issuer may file later universal registration documents without prior approval once it has had them approved for two consecutive financial years.
Current law (since 4 December 2024 (Regulation (EU) 2024/2809)): One financial year with an approved universal registration document is enough; missing a year's filing loses the benefit.
What must a prospectus contain, and in what form?
A prospectus must contain the necessary information that is material for an investor's informed assessment of three things: the financial position, assets and liabilities, profits and losses, and prospects of the issuer and of any guarantor; the rights attached to the securities; and the reasons for the issue and its impact on the issuer. What is needed varies with the issuer, the type of security and the circumstances.
It may be one document or separate documents. Separate documents split the content three ways: the issuer goes in a registration document, the securities in a securities note, and the essentials in a summary. Since 5 June 2026 a prospectus must generally follow a standardised format and sequence, now set out in Delegated Regulation (EU) 2026/1061 (in force since 16 August 2026), and must be easy to analyse, concise and comprehensible. A prospectus for shares may not exceed 300 A4 sides, not counting the summary or information incorporated by reference.
Terms used in this note
- Registration document
- The part of a prospectus containing the information on the issuer.
- Securities note
- The part containing the information on the securities offered or admitted.
- Final terms
- The details of an individual issue under a base prospectus.
- Frequent issuer
- An issuer with a universal registration document and up-to-date regulated information, entitled to five-working-day approval.
What goes in the summary and in a base prospectus?
The summary gives investors the key information on what the issuer, any guarantor and the securities are, and what risks they carry. It is read as an introduction, together with the rest of the prospectus. It must be accurate, fair and clear, must not mislead and must not contradict the rest of the prospectus. It is a short document of at most seven A4 sides in clear, non-technical, concise language, with four sections in a fixed order: an introduction with warnings, followed by key information about the issuer, then the securities, then the offer or admission. It may list no more than 15 risk factors and may not cross-refer to other parts. Since 5 June 2026 it may use charts, graphs and tables.
No summary is needed where the prospectus concerns the admission of non-equity securities to a regulated market and either the securities will trade only on a market or segment open solely to qualified investors, or they have a denomination of at least €100,000 per unit. The exam material lists these two conditions one after the other without saying whether both must be met. The Regulation, applicable in full since 21 July 2019, joins them with 'or': either condition alone removes the need for a summary.
A base prospectus is available for non-equity securities, warrants of any form included, as the issuer, offeror or person seeking admission prefers. The details of each issue follow in final terms. It must contain a template headed 'form of the final terms', showing the options to be fixed for each issue, and the web address at which final terms will appear. Final terms outside the base prospectus are filed with the home authority and published as soon as practicable, with a summary of the individual issue annexed.
How do universal registration documents, validity and supplements work?
Every issuer with securities on an MTF or a regulated market can prepare, each financial year, a universal registration document describing its organisation, business, finances, prospects, governance and shareholders. The first must be approved by the home authority. The exam material says later ones may be filed without prior approval once the issuer has had them approved for two consecutive financial years. Since 4 December 2024 the Listing Act requires only one financial year of approval; missing a year's filing loses the benefit. An issuer with such a document that confirms its regulated information under the Transparency Directive and MAR is up to date for the last 18 months (When and how must an issuer disclose inside information, and when may it delay?) is a frequent issuer: its prospectus in separate documents gets a decision within five working days, after five working days' notice.
A prospectus is valid for 12 months from approval, whether used for a public offer or an admission, if completed by any supplements required. For separate documents, the 12 months start when the securities note is approved. An approved registration document can serve within a prospectus for 12 months from its approval, and a universal registration document for 12 months from its approval or filing; their expiry does not end a prospectus they already belong to.
Between approval and the close of the offer period or the start of trading, whichever is later, any material mistake, material inaccuracy or significant new factor that could affect how the securities are assessed must go into a supplement without undue delay. It is approved like a prospectus, within at most five working days, and the summary is updated where needed. In a public offer, investors who had agreed to buy before publication may withdraw within three working days after it, if the new factor or error arose or was noted before the offer closed or the securities were delivered, whichever came first. Before 4 December 2024 the permanent rule was two working days. Since then a supplement may not add a new type of security to a base prospectus, unless capital requirements make it necessary.
How to think about it
Picture a kit: the registration document describes the issuer, the securities note the securities, and the summary the essentials. A base prospectus with final terms suits repeated non-equity issues; a universal registration document suits frequent issuers. Then the clock: 12 months of validity, kept current by supplements approved within five working days, with three working days for investors to withdraw.
Common mistakes
Requiring both conditions to drop the summary. For a non-equity admission, a qualified-investor-only market or a €100,000 denomination is enough on its own.
Waiting two years to file without approval. Since 4 December 2024 one approved financial year is enough.
Dating validity from the registration document. For separate documents, the 12 months run from approval of the securities note.
Stopping supplements when the offer closes. The duty lasts until the offer closes or trading starts, whichever is later.
Using a base prospectus for shares. It is only for non-equity securities, including warrants.
Legal references
- Regulation (EU) 2017/1129 (Prospectus Regulation), consolidated version of 5 June 2026 (opens in a new tab)
Article 6 (the prospectus; paragraphs 2 and 4 from 5 June 2026) · Article 7 (summary) · Article 8 (base prospectus) · Article 9 (universal registration document; paragraph 2 as amended from 4 December 2024) · Article 10 (separate documents) · Article 12 (validity) · Article 20(6) (frequent issuers) · Article 23 (supplements)
- Commission Delegated Regulation (EU) 2019/980 (format, content, scrutiny and approval of the prospectus), consolidated version of 18 June 2026 (opens in a new tab)
Schedules for the registration document and securities note; scrutiny and approval. Latest consolidation; does not yet include the 2026/1061 changes
- Commission Delegated Regulation (EU) 2026/1061 (standardised format and sequence; scrutiny and approval), amending Delegated Regulation (EU) 2019/980 (opens in a new tab)
Standardised format and sequence of prospectuses; in force 16 August 2026
- Commission Delegated Regulation (EU) 2019/979 (key financial information, publication, advertisements and supplements), consolidated version of 10 July 2026 (opens in a new tab)
Key financial information in the summary; supplements
- ESMA, Prospectus (issuer disclosure) page (opens in a new tab)
Q&As, guidelines and the September 2026 final reports and consultation under the amended Regulation
Practise this topic
Test what you just read
The Chapter 12 pack has 96 exam-style questions, 17 of them on this topic. Every question has a hint before you answer and a full explanation after.
Or revise the numbers first with 12 free Chapter 12 flashcards →